Gland Pharma has informed that it enclosed attached press release on ‘Gland Pharma receives tentative approval from the United States Food and Drug Administration (US FDA) for Angiotensin II for Injection, 2.5 mg/ ml Single-Dose Vial’
The above information is a part of company’s filings submitted to BSE.